By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050



Company News
Teva (TEVA)'s DuoResp Spiromax Wins Leading Award For Medical Design Excellence 7/6/2015 7:33:48 AM
Teva (TEVA) Launches Generic Aggrenox Capsules In The United States 7/1/2015 10:51:25 AM
Teva (TEVA) And Xenon Pharmaceuticals Inc. Provide Update On TV-45070 Phase IIb Study In Osteoarthritis Pain 7/1/2015 7:13:58 AM
Teva (TEVA) And Royal Philips Electronics N.V. (PHG) are Jointly Investing Up to $26.5 Million in Israeli Medical Device Firms 7/1/2015 6:30:39 AM
Teva (TEVA) And Active Biotech (BTPC) Announce Completion Of Patient Enrollment In Laquinimod Phase III CONCERTO Trial 6/25/2015 12:28:55 PM
Teva (TEVA) Completes The Purchase Of 4.61 Percent Interest In Mylan (MYL) 6/19/2015 8:11:36 AM
Momenta (MNTA) Announces CAFC Decision To Invalidate Remanded Teva (TEVA) Patent In Daily COPAXONE 20 Mg Suit 6/18/2015 11:14:39 AM
U.S. Court of Appeals for the Federal Circuit Finds Teva (TEVA)'s '808 Copaxone Patent Invalid 6/18/2015 11:02:53 AM
Teva (TEVA) To Present New Findings At The American Headache Society (AHS) Meeting – Analysis Of Migraine Phase Ilb Studies Provides Novel Insights Into TEV-48125 Efficacy And Safety In Both Episodic & Chronic Migraine 6/18/2015 10:11:53 AM
Teva (TEVA) In $35 Millon Deal With Implantable Drug-Delivery Device Maker Microchips Biotech 6/18/2015 10:09:21 AM